Maternal carbamazepine alters fetal neuroendocrine-cytokines axis

Main Author: R. G., Ahmed
Format: Dataset
Terbitan: Mendeley , 2017
Subjects:
Online Access: https:/data.mendeley.com/datasets/rt2h2mk9pf
ctrlnum 0.17632-rt2h2mk9pf.1
fullrecord <?xml version="1.0"?> <dc><creator>R. G., Ahmed</creator><title>Maternal carbamazepine alters fetal neuroendocrine-cytokines axis</title><publisher>Mendeley</publisher><description>This study detected the impact of maternal carbamazepine (CBZ) on the fetal neuroendocrine-cytokines axis. 25 or 50 mg/kg of CBZ was intraperitoneally administrated to pregnant albino rats from the gestation day (GD) 1 to 20. Both administrations of CBZ caused a hypothyroidism in dams and fetuses whereas the decreases in serum thyroxine (T4) and triiodothyronine (T3) and increases in serum thyrotropin (TSH) levels were highly significant (LSD; P &lt; 0.01) at GD 20 compared to untreated control dams. Also, both administrations had undesirable impacts on the maternofetal body weight, litter weight, survival of dams and fetuses, and their food consumption in comparison to the corresponding control. These administrations also elicited a reduction in fetal serum growth hormone (GH), interferon- g (IFNg), interleukins (IL-2 &amp; 4) and prostaglandin E2 (PGE2) levels. Also, the elevation in fetal serum tumor necrosis factor-alpha (TNFa), transforming growth factor-beta (TGFb), and interleukins (IL-1b &amp; 17) levels was observed at embryonic day (ED) 20. Moreover, there were a cellular fragmentation, distortion, hyperemia, oedema and vacuolation in the fetal cerebellar cortex due to both maternal administrations. These developmental changes were dose-dependent. These novel results suggest that CBZ may act as a developmental immunoneuroendocrine disruptor.</description><subject>Brain Development</subject><type>Other:Dataset</type><identifier>10.17632/rt2h2mk9pf.1</identifier><rights>Creative Commons Attribution 4.0 International</rights><rights>http://creativecommons.org/licenses/by/4.0</rights><relation>https:/data.mendeley.com/datasets/rt2h2mk9pf</relation><date>2017-09-21T11:23:42Z</date><recordID>0.17632-rt2h2mk9pf.1</recordID></dc>
format Other:Dataset
Other
author R. G., Ahmed
title Maternal carbamazepine alters fetal neuroendocrine-cytokines axis
publisher Mendeley
publishDate 2017
topic Brain Development
url https:/data.mendeley.com/datasets/rt2h2mk9pf
contents This study detected the impact of maternal carbamazepine (CBZ) on the fetal neuroendocrine-cytokines axis. 25 or 50 mg/kg of CBZ was intraperitoneally administrated to pregnant albino rats from the gestation day (GD) 1 to 20. Both administrations of CBZ caused a hypothyroidism in dams and fetuses whereas the decreases in serum thyroxine (T4) and triiodothyronine (T3) and increases in serum thyrotropin (TSH) levels were highly significant (LSD; P < 0.01) at GD 20 compared to untreated control dams. Also, both administrations had undesirable impacts on the maternofetal body weight, litter weight, survival of dams and fetuses, and their food consumption in comparison to the corresponding control. These administrations also elicited a reduction in fetal serum growth hormone (GH), interferon- g (IFNg), interleukins (IL-2 & 4) and prostaglandin E2 (PGE2) levels. Also, the elevation in fetal serum tumor necrosis factor-alpha (TNFa), transforming growth factor-beta (TGFb), and interleukins (IL-1b & 17) levels was observed at embryonic day (ED) 20. Moreover, there were a cellular fragmentation, distortion, hyperemia, oedema and vacuolation in the fetal cerebellar cortex due to both maternal administrations. These developmental changes were dose-dependent. These novel results suggest that CBZ may act as a developmental immunoneuroendocrine disruptor.
id IOS7969.0.17632-rt2h2mk9pf.1
institution Universitas Islam Indragiri
affiliation onesearch.perpusnas.go.id
institution_id 804
institution_type library:university
library
library Teknologi Pangan UNISI
library_id 2816
collection Artikel mulono
repository_id 7969
city INDRAGIRI HILIR
province RIAU
shared_to_ipusnas_str 1
repoId IOS7969
first_indexed 2020-04-08T08:11:09Z
last_indexed 2020-04-08T08:11:09Z
recordtype dc
_version_ 1686587387906359296
score 17.538404